| Scientific Name | Fingolimod |
|---|---|
| Brand Name | Gilenya |
| Risk | Safety information about contraindication in pregnant women and in women of childbearing potential not using effective contraception, Communication on progressive multifocal leukoencephalopathy (PML) , Hemophagocytic syndrome (HPS), Cardiovascular, Adverse Events after the First Dose, Slow heart rate and irregular heartbeat, Instructions for proper use, Updated recommendations to minimize the risk of drug-induced liver injury (DILI). |
| Safety Communication for Healthcare Professionals |
